Tuberculosis Co-Infection Is Common in Patients Requiring Hospitalization for COVID-19 in Belarus: Mixed-Methods Study
Yuliia Sereda(World Health Organization Regional Office for Europe), Alena Skrahina(Republican Scientific and Practical Centre of Pulmonology and Tuberculosis), Askar Yedilbayev(World Health Organization Regional Office for Europe), Viatcheslav Grankov(Ministry of Health), Dzmitry Klimuk(Republican Scientific and Practical Centre of Pulmonology and Tuberculosis), Oleksandr Korotych(World Health Organization Regional Office for Europe), Hennadz Hurevich(Republican Scientific and Practical Centre of Pulmonology and Tuberculosis), Varvara Solodovnikova(Republican Scientific and Practical Centre of Pulmonology and Tuberculosis), Malgorzata Grzemska(World Health Organization Regional Office for Europe), Dzmitry Zhurkin(Republican Scientific and Practical Centre of Pulmonology and Tuberculosis)
International Journal of Environmental Research and Public Health
April 5, 2022
Cited by 12
Related Papers
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study
|The Lancet Infectious Diseases|2017|688
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report
|European Respiratory Journal|2019|176
The TB Portals: an Open-Access, Web-Based Platform for Global Drug-Resistant-Tuberculosis Data Sharing and Analysis
|Journal of Clinical Microbiology|2017|140
Reducing tuberculosis transmission: a consensus document from the World Health Organization Regional Office for Europe
|European Respiratory Journal|2019|130